Tetrahydronaphthyridine derivatives
    4.
    发明授权
    Tetrahydronaphthyridine derivatives 失效
    四氢萘并吡啶衍生物

    公开(公告)号:US07557121B2

    公开(公告)日:2009-07-07

    申请号:US11128804

    申请日:2005-05-12

    IPC分类号: A61K31/44 C07D515/02

    CPC分类号: C07D471/04

    摘要: The present invention relates to tetrahydronaphthyridine derivatives of the general formula (I): or of the general formula (I′) in which A and R1 are as defined within, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, including the treatment diseases mediated by H3 ligands, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

    摘要翻译: 本发明涉及通式(I)的四氢萘并吡啶衍生物:或其中A和R 1如上所定义的通式(I')的化合物,以及制备用于制备组合物的中间体的方法 包括由H3配体介导的治疗疾病,特别是炎性,过敏性和呼吸道疾病,病症和病症的用途。

    Tetrahydronaphthyridine Derivatives
    6.
    发明申请
    Tetrahydronaphthyridine Derivatives 审中-公开
    四氢萘并吡啶衍生物

    公开(公告)号:US20090258861A1

    公开(公告)日:2009-10-15

    申请号:US12491370

    申请日:2009-06-25

    CPC分类号: C07D471/04

    摘要: The present invention relates to tetrahydronaphthyridine derivatives of the general formula (I): or of the general formula (I′) in which A and R1 are as defined within, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, including the treatment diseases mediated by H3 ligands, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

    摘要翻译: 本发明涉及通式(I)的四氢萘并吡啶衍生物:或其中A和R 1如上所定义的通式(I')的化合物,以及制备用于制备组合物的中间体的方法 包括由H3配体介导的治疗疾病,特别是炎性,过敏性和呼吸道疾病,病症和病症的用途。